Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34097854

Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2021 Jun 19
First author
Moreau P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2021 Jun 19;397(10292):2311-2313. doi: 10.1016/S0140-6736(21)00729-7.
    note
    Source null
    related pmid
    34097855
    relationship
    Comment in

Authors and identifiers

  1. name
    Moreau P
    type
    Author
  2. name
    Dimopoulos MA
    type
    Author
  3. name
    Mikhael J
    type
    Author
  4. name
    Yong K
    type
    Author
  5. name
    Capra M
    type
    Author
  6. name
    Facon T
    type
    Author
  7. name
    Hajek R
    type
    Author
  8. name
    Špička I
    type
    Author
  9. name
    Baker R
    type
    Author
  10. name
    Kim K
    type
    Author
  11. name
    Martinez G
    type
    Author
  12. name
    Min CK
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Moreau P
    type
    Author
  2. name
    Dimopoulos MA
    type
    Author
  3. name
    Mikhael J
    type
    Author
  4. name
    Yong K
    type
    Author
  5. name
    Capra M
    type
    Author
  6. name
    Facon T
    type
    Author
  7. name
    Hajek R
    type
    Author
  8. name
    Špička I
    type
    Author
  9. name
    Baker R
    type
    Author
  10. name
    Kim K
    type
    Author
  11. name
    Martinez G
    type
    Author
  12. name
    Min CK
    type
    Author
bibliography ids
  1. nci-bib-bdd4280c91a27fce835bd176
book metadata
content sha256
9521e3c69c5950ded96e09fe3f7174fca2ab13867302fd4442431f66909b08d5
document type
citation
dois
  1. 10.1016/S0140-6736(21)00592-4
electronic publication date
display
2021 Jun 4
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:34097854
immutable id
pubmed:34097854@9521e3c69c5950ded96e09fe3f7174fca2ab13867302fd4442431f66909b08d5
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10292
name
Lancet (London, England)
nlm unique id
2985213R
pages
2361-2371
volume
397
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2021 Jun 19;397(10292):2311-2313. doi: 10.1016/S0140-6736(21)00729-7.
    note
    Source null
    related pmid
    34097855
    relationship
    Comment in
outcomes validated
false
pmid
34097854
provenance
batch id
79f1021053e858d13ff3
provider
NCBI PubMed ESummary
record sha256
f2ee78f0e08647c408f956db06c919cc9f9cce790390e88ba9d1997b371304f3
response sha256
671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
retrieved at
2026-09-09T23:47:59.098265+00:00
publication date
display
2021 Jun 19
precision
day
year
2021
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34097854/
title
Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial.

Preserved source evidence · Not medical advice